News

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...
A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.
While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...
Interest in weight-loss medications is at an all-time high, with promising study results and inspiring success stories coming ...
A recent study from the University of Pennsylvania has shown that the injectable drug semaglutide can help people lose a ...
A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug ...
Semaglutide increased maximum walking distance ... is currently indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2D; to reduce the risk of major adverse ...
Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...